Patients With Worst COVID-19 May Be Best Plasma Donors: Study
TUESDAY, Oct. 27, 2020 -- Factors such as sex, age and severity of the disease may help identify COVID-19 survivors who have high levels of antibodies that can protect against the disease, a new study suggests.
"These were significant patient characteristics that not only predicted the amount of antibody but the quality of that antibody," said lead author Sabra Klein, a professor in the Department of Molecular Microbiology and Immunology at Johns Hopkins Bloomberg School of Public Health in Baltimore.
Specifically, older men who have recovered after a hospital stay for COVID-19 may be good candidates for donating plasma for treating other infected patients, the study suggests.
Plasma trials are continuing, but doctors are unsure how to select COVID-19 survivors who are most likely to have strong antibody responses.
For the study, researchers tested the blood of 126 COVID-19 survivors and found many differences in their antibody levels and their antibodies' ability to neutralize SARS-CoV-2. Factors linked with stronger antibody responses included being sick enough to be hospitalized, being older and being male.
"We know that the magnitude of antibody responses correlates with disease severity in other infectious diseases, such as active tuberculosis," Klein said in a Hopkins news release.
The findings were recently published in the Journal of Clinical Investigation.
© 2021 HealthDay. All rights reserved.
Posted: October 2020
Further Support and Information on COVID-19
Read this next
MONDAY, Jan. 18, 2021 -- Despite being locked down during the pandemic, child care responsibilities often fell on women's shoulders, a new study shows. "Most people have never...
SATURDAY, Jan. 16, 2021 -- President-elect Joe Biden described an ambitious national vaccination plan on Friday that will deliver coronavirus vaccines to far more people and...
FRIDAY, Jan. 15, 2021 (American Heart Association News) -- Experts have a simple answer for heart and stroke patients questioning whether they need a COVID-19 vaccination. That...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.